Table 4.
Multivariate analysis of predictive factors associated with positive SBCE findings in overt OGIB patients on antithrombotic agents
| Variables | Reference | OR | 95% CI | p |
|---|---|---|---|---|
| Hemoglobin level (per 1 g/dl decrease) | 1.189 | 1.012–1.397 | 0.035 | |
| Smoking habit | Non-smoking | 3.262 | 0.97–10.914 | 0.055 |
| PPI use | Non-user | 1.62 | 0.773–3.395 | 0.201 |
| Discontinuation of antithrombotics | Continuation | 1.579 | 0.749–3.326 | 0.23 |
| CCI ≥5 | CCI <5 | 2.518 | 0.480–13.210 | 0.275 |
SBCE, small bowel capsule endoscopy; OGIB, obscure gastrointestinal bleeding; OR, odds ratio; CI, confidence interval; PPI, proton pump inhibitors; CCI, Charlson comorbidity index.